Decompressive hemicraniectomy for ischemic stroke in the pediatric population

Area of Science:

• Neurology
• Neurosurgery
• Pediatric Critical Care

Background:

• Space-occupying hemispheric infarctions carry a high fatality rate (80%) in adults.
• Decompressive hemicraniectomy (DH) is a treatment for malignant cerebral infarction in adults, with optimal outcomes if performed within 48 hours.
• Limited randomized controlled trials exist for DH in pediatric malignant stroke.

Purpose of the Study:

• To evaluate the current literature on DH for pediatric malignant stroke.
• To assess the efficacy and outcomes of DH in the pediatric population.
• To compare pediatric DH outcomes with established adult data.

Main Methods:

• Literature review of studies involving decompressive hemicraniectomy in pediatric patients with malignant stroke.
• Analysis of existing case series and observational data.
• Comparison of outcomes based on timing of intervention.

Main Results:

• Excellent recovery and acceptable quality of life are possible with DH in pediatric patients.
• Intervention beyond the 48-hour window may still yield positive outcomes in children, contrasting with adult data.
• The pediatric population appears to tolerate and benefit from DH differently than adults.

Conclusions:

• Decompressive hemicraniectomy is a viable treatment option for pediatric malignant stroke.
• The optimal timing for DH in pediatric patients may extend beyond 48 hours.
• Further randomized controlled trials are necessary to establish optimal timing and identify outcome predictors in pediatric DH for stroke.